황금 (Scutellaria baicalensis) 추출물의 ECS조절을 통한 아토피피부염 염증 완화 효과

키워드

참고문헌 (36)

1. Manzanares J, "Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes", Curr Neuropharmacol, 4(3), pp.239~257 (2006)
2. Pacher P, "The endocannabinoid system as an emerging target of pharmacotherapy", Pharmacol Rev, 58(3), pp.389~462 (2006)
3. Miller LK, "The highs and lows of cannabinoid receptor expression in disease : mechanisms and their therapeutic implications", Pharmacol Rev, 63(3), pp.461~470 (2011)
4. Luger TA, "Neuromediators--a crucial component of the skin immune system", J Dermatol Sci, 30(2), pp.87~93 (2002)
5. Maccarrone M, "The endocannabinoid system in human keratinocytes : evidence that anandamide inhibits epidermal differentiation through CB1receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase", J Biol Chem, 278(36), pp.33896~33903 (2003)
6. Karsak M, "Attenuation of allergic contact dermatitis through the endocannabinoid system", Science, 316(5830), pp.1494~1497 (2007)
7. Casanova ML, "Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors", J Clin Invest, 111(1), pp.43~50 (2003)
8. Gaffal E, "Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation", J Immunol, 190(10), pp.4929~4936 (2013)
9. Walker JM, "Cannabinoid mechanisms of pain suppression", Handb Exp Pharmacol, 168, pp.509~554 (2005)
10. Jhaveri MD, "Endocannabinoid metabolism and uptake : novel targets for neuropathic and inflammatory pain", Br J Pharmacol, 152(5), pp.624~632 (2007)
11. Tóth BI, "Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1", J Invest Dermatol, 131(5), pp.1095~1104 (2011)
12. Tóth KF, "Cannabinoid signaling in the skin : therapeutic potential of the"C(ut)annabinoid"system", Molecules, 24(5), pp.918~ (2019)
13. Egawa G, "Barrier dysfunction in the skin allergy", Allegology International, 67(1), pp.3~11 (2018)
14. Takei K, "Galactomyces fermentation filtrate prevents T helper2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner", Clin Exp Dermatol, 40(7), pp.786~793 (2015)
15. Takei K, "Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor", J Dermatol, 42(2), pp.171~180 (2015)
16. Tenn MW, "The clinical relevance of filaggrin mutations : effect on allergic disease", Ann Allergy Asthma Immunol, 117(5), pp.483~489 (2016)
17. The textbook compilation committee of Korean herbology, "Bonchohak", pp.218~220 (2010), Younglimsa
18. 박완수, "黃芩 물추출물이 마우스 대식세포의 hydrogen peroxide 생성에 미치는 영향", 대한본초학회지, 26(1), pp.53~58 (2011), 대한본초학회
19. 양버들, "황금 추출물이 생쥐에 유발된 접촉피부염의 피부 증상에 미치는 영향", 동의생리병리학회지, 31(1), pp.59~64 (2017), 한의병리학회[DOI]
20. 박영숙, "황금열수추출물이 DNCB로 유도된 알레르기성 접촉피부염 흰쥐의 항산화능 및 표피회복능에 미치는 영향", 한국식품영양과학회지, 35(6), pp.543~548 (2006), 한국식품영양과학회
21. 김보애, "황련해독탕이 NC", Nga Mice에서 유발된 아토피 피부염에 미치는 영향, 2008, pp.23(2), 59~65[DOI]
22. 안상현, "황금추출물의 지방장벽 생성을 통한 염증완화 효과", 대한한방소아과학회지, 35(1), pp.40~47 (2021), 대한한방소아과학회
23. Jun JH, "The effects of Scutellaria baicalensis GEORGI on allergic contact dermatitis induced by DNCB in mice", D. J. I. O. M, 7(1), pp.119~133 (1998)
24. Joo KM, "Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins", J Dermatol Sci, 77(1), pp.71~74 (2015)
25. 정복기, "Inhibitory effects of interleukin-10 plasmid DNA on the development of atopic dermatitis-like skin lesions in NC", Nga mice, 2010, pp.11(3), 213~220[DOI]
26. Amin K, "The role of mast cells in allergic inflammation", Respir. Med, 106(1), pp.9~14 (2012)
27. Cha HY, "Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC", Nga mice under high-fat diet conditions, 2016, pp.2016, 1739760~
28. Woessner JF Jr, "MMPs and TIMPs-an historical perspective", Mol Biotechnol, 22(1), pp.33~49 (2002)
29. Burrage PS, "Matrix metalloproteinases : role in arthritis", Front Biosci, 11(1), pp.529~543 (2006)
30. Onodera S, "Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblast of rheumatoid arthritis", J Biol Chem, 275(1), pp.444~450 (2000)
31. Salzet M, "Invertebrate molecular neuroimmune processes", Brain Res Rev, 34(1), pp.69~79 (2000)
32. Yang H, "GPR55-a putative"type 3"cannabinoid receptor in inflammation", J Basic Clin Physiol Pharmacol, 27(3), pp.297~302 (2016)
33. 남개원, "Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model", Annals of Dermatology, 28(1), pp.22~29 (2016), 대한피부과학회
34. Kim HJ, "Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model", Int J Dermatol, 54(10), pp.401~408 (2015)
35. Haruna T, "The inhibitory effect of S-777469, a cannabinoid type 2 receptor agonist, on skin inflammation in mice", Pharmacology, 99, pp.259~267 (2017)
36. Cantarella G, "Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells", Biochem Pharmacol, 82(4), pp.380~388 (2011)

관련 논문AI추천